Navigation Links
Study: Most young violent offenders in two NYC neighborhoods have seen someone killed
Date:1/13/2009

interviews suggest that these youth and young men have developed internalized "scripts" that help them determine how to respond in dangerous situations.

Most of the participants have seen violence used as a way to work through problems all their lives, and as a result their scripts often include violence as a way of reacting when someone confronts them or shows them disrespect.

"The early exposure to violence teaches them a limited repertoire of what options they have in a particular dangerous setting," she said. "We found in the interviews that kids use violence when they think it is necessary to get through a situation and maintain their respect.

"These youth do not feel safe in their neighborhoods. They do not feel protected by the police or community adults."

The participants in the study were selected from three groups: one group had been convicted and jailed for illegal handgun possession or a violent offense; another group had been in a hospital for injuries resulting from violence; and the third group had been identified as being actively involved in violence during the past six months.

All participants were interviewed for 1 to 2 hours by peer interviewers young men from the same neighborhoods who were recruited and trained by the researchers.

The 416 participants discussed in detail 780 violent events in which they had been involved, and revealed how they psychologically processed these experiences.

For most of those interviewed, guns were a part of life, Wilkinson said.

Thirty percent of those surveyed said they carried a gun every day, and 92 percent reported they were carrying a gun at the time they were interviewed for this study.

Self-protection was one of the main reasons cited for carrying a gun.

"In the interviews, a lot of the kids defined themselves as non-violent, but at the same time they carry guns and they have used guns," Wilkinson said.

"The
'/>"/>

Contact: Deanna Wilkinson
Wilkinson.110@osu.edu
614-247-4004
Ohio State University
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Penn study: Chances of surviving cardiac arrest depend on where patients are treated
2. Study: Fluoridation Benefits Doubtful
3. Study: How Can States Treat a Sick Economy? Call the Doctors
4. Study: Sandwich Generation Struggling With Dual Caregiver Responsibilities
5. New Easter Seals-MassMutual Study: Autism Strains Family Finances, Threatens Long-Term Care and Security
6. Study: Patient Harm More Common with Patient-Controlled Pain Medication
7. Study: Childhood constipation just as serious as asthma
8. Study: Want to be happier? Be more grateful
9. Study: Smoking Ban Would Help Reduce Heart Attack Admissions
10. New study: A Common Class of GI Medications Reduce Protection Against Heart Attack in Patients Taking Widely Prescribed Cardiovascular Drug
11. University of Illinois - Chicago Study: Raisins Contain Compounds that May Inhibit Cavity-causing Bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18Vivakor Announces New Acquisition Strategy 2AMT Provides Business Update for the Third Quarter 2009 14895 1AMT Provides Business Update for the Third Quarter 2009 14895 2AMT Provides Business Update for the Third Quarter 2009 14895 3AMT Provides Business Update for the Third Quarter 2009 14895 4Enigma Diagnostics Showcases Its Unique Fully Automated rtPCR Based ML 28Mini Laboratory 29 Instrument For Point of Care Testing at MEDICA 2009 In Du 6362 1Enigma Diagnostics Showcases Its Unique Fully Automated rtPCR Based ML 28Mini Laboratory 29 Instrument For Point of Care Testing at MEDICA 2009 In Du 6362 2Enigma Diagnostics Showcases Its Unique Fully Automated rtPCR Based ML 28Mini Laboratory 29 Instrument For Point of Care Testing at MEDICA 2009 In Du 6362 3Netech Corporation Announces the Release of IPA 2000 Infusion Pump Analyzer for Fast and Accurate Testing of All Infusion Pumps 14891 1Netech Corporation Announces the Release of IPA 2000 Infusion Pump Analyzer for Fast and Accurate Testing of All Infusion Pumps 14891 2
Other Medicine Technology:Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 2Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 3Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 4Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 5Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 6Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 7Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine 2Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine 3Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine 4